WHO experts suggest antiviral drug for patients with non-severe covid-19 at highest risk of hospitalization

The antiviral drug molnupiravir is conditionally recommended for patients with non-severe covid-19 who are at highest risk of hospitalization, says a WHO Guideline Development Group of international experts in The BMJ today.

Related Keywords

,Emily Henderson ,Guideline Development Group ,Evidence Ecosystem Foundation ,World Health Organization ,Development Group ,Ecosystem Foundation ,Antiviral Drug ,Covid 19 ,Hospital ,Breastfeeding ,Children ,Hronic ,Coronavirus ,Medicine ,Micron ,Research ,